Ignite Creation Date:
2025-12-25 @ 4:18 AM
Ignite Modification Date:
2026-06-25 @ 3:07 AM
Study NCT ID:
NCT01249820
Status:
COMPLETED
Last Update Posted:
2020-12-08
First Post:
2010-08-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pharmacokinetics of Anidulafungin (Ecalta ®) Intravenous Given to Patients at High Risk for Developing Invasive Fungal Disease
Sponsor:
Radboud University Medical Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
UMCN-AKF 10.01 / SC25
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None